(Q33462220)

English

Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines (English)

1 reference

Europe PubMed Central

27 July 2017

author name string

P M Parreiras

1

1 reference

Europe PubMed Central

27 July 2017

L A Sirota

2

1 reference

Europe PubMed Central

27 July 2017

L D Wagner

3

1 reference

Europe PubMed Central

27 July 2017

S L Menzies

4

1 reference

Europe PubMed Central

27 July 2017

J L Arciniega

5

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

6 June 2009

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

27

1 reference

Europe PubMed Central

27 July 2017

33

1 reference

Europe PubMed Central

27 July 2017

4537-4542

1 reference

Europe PubMed Central

27 July 2017

Anthrax in Europe: its epidemiology, clinical characteristics, and role in bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Endemic, Notifiable Bioterrorism-Related Diseases, United States, 1992–1999

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Iraq's biological weapons. The past as future?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Bioterrorism preparedness and response: clinicians and public health agencies as essential partners

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Biodefense R&D: anticipating future threats, establishing a strategic environment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Validation of the anthrax lethal toxin neutralization assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Measuring agreement in method comparison studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Development of an in vitro-based potency assay for anthrax vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

A concordance correlation coefficient to evaluate reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Measurement in Medicine: The Analysis of Method Comparison Studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of parallelism and nonparallelism in bioassay dilution curves.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.05.045

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33462220&oldid=1607182027"